The Melbourne company dosed the first patient in its Beyond Harmony study of NTI164 on 21 September. All six sites across ...
Health and Me on MSN
‘Ozempic of autism’: Experimental drug shows symptom improvements in nonverbal boy with ASD
L1-79 is an oral drug developed by Yamo Pharmaceuticals to target autism’s core symptoms. About 116 patients have reportedly ...
A particular signaling protein in the brain could be a therapeutic target for neurological disorders arising from the ...
An oral drug designed to treat the core symptoms of autism spectrum disorder, has been dubbed by some as 'the Ozempic of ...
October 26, 2026) - Adia Med Inc. (OTCQB: ADIA) today reported interim safety observations from the first cohort of its ...
A new scientific avenue for daridorexant: Idorsia to advance development in autism spectrum disorder
In a Phase 2 study in pediatric insomnia disorder, in addition to marked improvements in sleep measures, daridorexant 50 mg showed an unexpected pattern of improvement in affect and behavior, ...
Ad hoc announcement pursuant to Art. 53 LR In a Phase 2 study in pediatric insomnia disorder, in addition to marked improvements in sleep measures, daridorexant 50 mg showed an unexpected pattern of ...
This report has been edited to look at ICB plans for remodelling ADHD and autism services Kent and Medway Integrated Care ...
Kent's NHS spending on autism and ADHD services has rocketed from just £640,000 to almost £29 million in two years. We look at the reasons ...
For months, multiple sclerosis seemed to explain what was happening to my body. Finding the right diagnosis meant confronting ...
Receiving an autism diagnosis later in life brings up complex emotions. For those with eating disorders, it could be the key ...
Lebanon’s Autism Awareness Association (AAA) has provided support for both mother and child. Vana has attended classes at AAA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results